138 related articles for article (PubMed ID: 18718080)
1. [Expression and function of non-muscle myosin-IIA in Fechtner syndrome].
Yang HY; Wang ZY; Cao LJ; Zhao XJ; Bai X; Ruan CG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):871-4. PubMed ID: 18718080
[TBL] [Abstract][Full Text] [Related]
2. Non-muscle myosin heavy chain IIA and IIB interact and co-localize in living cells: relevance for MYH9-related disease.
Marini M; Bruschi M; Pecci A; Romagnoli R; Musante L; Candiano G; Ghiggeri GM; Balduini C; Seri M; Ravazzolo R
Int J Mol Med; 2006 May; 17(5):729-36. PubMed ID: 16596254
[TBL] [Abstract][Full Text] [Related]
3. Cloning of the murine non-muscle myosin heavy chain IIA gene ortholog of human MYH9 responsible for May-Hegglin, Sebastian, Fechtner, and Epstein syndromes.
D'Apolito M; Guarnieri V; Boncristiano M; Zelante L; Savoia A
Gene; 2002 Mar; 286(2):215-22. PubMed ID: 11943476
[TBL] [Abstract][Full Text] [Related]
4. [Autosomal dominant macrothrombocytopenia with leukocyte inclusion bodies and MYH9 disorders].
Kunishima S
Rinsho Byori; 2009 Apr; 57(4):365-70. PubMed ID: 19489439
[TBL] [Abstract][Full Text] [Related]
5. Pathogenetic mechanisms of hematological abnormalities of patients with MYH9 mutations.
Pecci A; Canobbio I; Balduini A; Stefanini L; Cisterna B; Marseglia C; Noris P; Savoia A; Balduini CL; Torti M
Hum Mol Genet; 2005 Nov; 14(21):3169-78. PubMed ID: 16162639
[TBL] [Abstract][Full Text] [Related]
6. Haematological characteristics of MYH9 disorders due to MYH9 R702 mutations.
Kunishima S; Yoshinari M; Nishio H; Ida K; Miura T; Matsushita T; Hamaguchi M; Saito H
Eur J Haematol; 2007 Mar; 78(3):220-6. PubMed ID: 17241369
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disorders.
Pecci A; Noris P; Invernizzi R; Savoia A; Seri M; Ghiggeri GM; Sartore S; Gangarossa S; Bizzaro N; Balduini CL
Br J Haematol; 2002 Apr; 117(1):164-7. PubMed ID: 11918549
[TBL] [Abstract][Full Text] [Related]
8. Dysmegakaryopoiesis of FPD/AML pedigrees with constitutional RUNX1 mutations is linked to myosin II deregulated expression.
Bluteau D; Glembotsky AC; Raimbault A; Balayn N; Gilles L; Rameau P; Nurden P; Alessi MC; Debili N; Vainchenker W; Heller PG; Favier R; Raslova H
Blood; 2012 Sep; 120(13):2708-18. PubMed ID: 22898599
[TBL] [Abstract][Full Text] [Related]
9. Defective expression of GPIb/IX/V complex in platelets from patients with May-Hegglin anomaly and Sebastian syndrome.
Di Pumpo M; Noris P; Pecci A; Savoia A; Seri M; Ceresa IF; Balduini CL
Haematologica; 2002 Sep; 87(9):943-7. PubMed ID: 12217806
[TBL] [Abstract][Full Text] [Related]
10. Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome).
Ghiggeri GM; Caridi G; Magrini U; Sessa A; Savoia A; Seri M; Pecci A; Romagnoli R; Gangarossa S; Noris P; Sartore S; Necchi V; Ravazzolo R; Balduini CL
Am J Kidney Dis; 2003 Jan; 41(1):95-104. PubMed ID: 12500226
[TBL] [Abstract][Full Text] [Related]
11. Establishment of mouse model of MYH9 disorders: heterozygous R702C mutation provokes macrothrombocytopenia with leukocyte inclusion bodies, renal glomerulosclerosis and hearing disability.
Suzuki N; Kunishima S; Ikejiri M; Maruyama S; Sone M; Takagi A; Ikawa M; Okabe M; Kojima T; Saito H; Naoe T; Matsushita T
PLoS One; 2013; 8(8):e71187. PubMed ID: 23976996
[TBL] [Abstract][Full Text] [Related]
12. [May-Hegglin anomaly: past and present--novel diagnostic test and new concept of the disease].
Kunishima S
Rinsho Byori; 2009 Jan; 57(1):54-9. PubMed ID: 19227191
[TBL] [Abstract][Full Text] [Related]
13. Distinct roles of nonmuscle myosin II isoforms in the regulation of MDA-MB-231 breast cancer cell spreading and migration.
Betapudi V; Licate LS; Egelhoff TT
Cancer Res; 2006 May; 66(9):4725-33. PubMed ID: 16651425
[TBL] [Abstract][Full Text] [Related]
14. Mutations in human nonmuscle myosin IIA found in patients with May-Hegglin anomaly and Fechtner syndrome result in impaired enzymatic function.
Hu A; Wang F; Sellers JR
J Biol Chem; 2002 Nov; 277(48):46512-7. PubMed ID: 12237319
[TBL] [Abstract][Full Text] [Related]
15. Nonmuscle Myosin Heavy Chain IIA Mutation Predicts Severity and Progression of Sensorineural Hearing Loss in Patients With MYH9-Related Disease.
Verver EJ; Topsakal V; Kunst HP; Huygen PL; Heller PG; Pujol-Moix N; Savoia A; Benazzo M; Fierro T; Grolman W; Gresele P; Pecci A
Ear Hear; 2016; 37(1):112-20. PubMed ID: 26226608
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructural analysis of granulocyte inclusions in genetically confirmed MYH9-related disorders.
Pujol-Moix N; Kelley MJ; Hernández A; Muñiz-Diaz E; Español I
Haematologica; 2004 Mar; 89(3):330-7. PubMed ID: 15020273
[TBL] [Abstract][Full Text] [Related]
17. Asymmetric distribution of myosin IIB in migrating endothelial cells is regulated by a rho-dependent kinase and contributes to tail retraction.
Kolega J
Mol Biol Cell; 2003 Dec; 14(12):4745-57. PubMed ID: 12960430
[TBL] [Abstract][Full Text] [Related]
18. Clinical manifestation and molecular genetic characterization of MYH9 disorders.
Provaznikova D; Geierova V; Kumstyrova T; Kotlin R; Mikulenkova D; Zurkova K; Matoska V; Hrachovinova I; Rittich S
Platelets; 2009 Aug; 20(5):289-96. PubMed ID: 19557653
[TBL] [Abstract][Full Text] [Related]
19. Distinct roles for non-muscle myosin II isoforms in mouse hepatic stellate cells.
Liu Z; Van Rossen E; Timmermans JP; Geerts A; van Grunsven LA; Reynaert H
J Hepatol; 2011 Jan; 54(1):132-41. PubMed ID: 20932596
[TBL] [Abstract][Full Text] [Related]
20. The distinct roles of myosin IIA and IIB under compression stress in nucleus pulposus cells.
Ke W; Wang B; Hua W; Song Y; Lu S; Luo R; Li G; Wang K; Liao Z; Xiang Q; Li S; Wu X; Zhang Y; Yang C
Cell Prolif; 2021 Feb; 54(2):e12987. PubMed ID: 33415745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
